SPIA
GH icon

Steward Partners Investment Advisory’s Guardant Health GH Stock Holding History

Steward Partners Investment Advisory’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.3K Sell
495
-487
-50% -$53K ﹤0.01% 2748
2026
Q1 		$90.7K Sell
982
-70
-7% -$7.03K ﹤0.01% 2432
2025
Q4 		$107K Sell
1,052
-75
-7% -$6.71K ﹤0.01% 2253
2025
Q3 		$70.4K Buy
1,127
+140
+14% +$7.62K ﹤0.01% 2441
2025
Q2 		$51.4K Hold
987
– – ﹤0.01% 2467
2025
Q1 		$42K Buy
987
+912
+1,216% +$39.3K ﹤0.01% 2473
2024
Q4 		$2.29K Buy
+75
New +$2.11K ﹤0.01% 3603
2024
Q3 		– Sell
-465
Closed -$13.4K – 3785
2024
Q2 		$13.4K Sell
465
-900
-66% -$21K ﹤0.01% 2693
2024
Q1 		$28.2K Buy
1,365
+585
+75% +$12.5K ﹤0.01% 2367
2023
Q4 		$21.1K Buy
780
+50
+7% +$1.31K ﹤0.01% 2385
2023
Q3 		$21.6K Buy
730
+200
+38% +$7.03K ﹤0.01% 2270
2023
Q2 		$19K Hold
530
– – ﹤0.01% 2317
2023
Q1 		$12.4K Buy
530
+5
+1% +$143 ﹤0.01% 2458
2022
Q4 		$14.3K Sell
525
-36
-6% -$1.65K ﹤0.01% 2403
2022
Q3 		$30K Sell
561
-17
-3% -$873 ﹤0.01% 2026
2022
Q2 		$23K Sell
578
-20
-3% -$991 ﹤0.01% 2155
2022
Q1 		$40K Sell
598
-127
-18% -$8.69K ﹤0.01% 2034
2021
Q4 		$73K Hold
725
– – ﹤0.01% 1726
2021
Q3 		$91K Sell
725
-104
-13% -$12.4K ﹤0.01% 1593
2021
Q2 		$103K Buy
829
+535
+182% +$72K ﹤0.01% 2217
2021
Q1 		$44.9K Buy
294
+245
+500% +$37K ﹤0.01% 2040
2020
Q4 		$6K Buy
49
+9
+23% +$1.04K ﹤0.01% 2461
2020
Q3 		$4K Sell
40
-100
-71% -$9.15K ﹤0.01% 2425
2020
Q2 		$11K Hold
140
– – ﹤0.01% 2000
2020
Q1 		$9K Sell
140
-100
-42% -$7.67K ﹤0.01% 1899
2019
Q4 		$18K Sell
240
-312
-57% -$22.5K ﹤0.01% 1804
2019
Q3 		$35K Sell
552
-412
-43% -$36.3K ﹤0.01% 1509
2019
Q2 		$83K Buy
+964
New +$73.6K ﹤0.01% 1128

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Steward Partners Investment Advisory's GH Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Guardant Health (GH) stake by 50% in Q2 2026, selling an estimated $53K and leaving 495 shares worth $74.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2748.

Steward Partners Investment Advisory first reported a position in GH in Q2 2019 and has held it in 28 quarters since. The position peaked at $107K in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Steward Partners Investment Advisory held 495 shares of Guardant Health worth $74.3K as of Q2 2026.
  • Steward Partners Investment Advisory sold 487 Guardant Health shares in Q2 2026, an estimated $53K.
  • Guardant Health made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2748 holding.
  • Steward Partners Investment Advisory first reported a position in Guardant Health in Q2 2019 and has held it in 28 quarters since.
  • Steward Partners Investment Advisory's Guardant Health position peaked at $107K in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.